Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,179
Total Claims
$588K
Drug Cost
511
Beneficiaries
$1,151
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+219%
Opioid rate vs peers
8.2% vs 2.6% avg
+8%
Cost per patient vs peers
$1,151 vs $1,068 avg
+116%
Brand preference vs peers
19.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 219% above Family Practice peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
8.2%
Opioid Rate
755
Opioid Claims
$25K
Opioid Cost
11.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,776 claims · $405K
Generic: 7,376 claims · $182K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 69 | $73K |
| Apixaban | 252 | $71K |
| Dapagliflozin Propanediol | 69 | $28K |
| Empagliflozin | 51 | $19K |
| Rivaroxaban | 68 | $13K |
| Hydrocodone/Acetaminophen | 463 | $12K |
| Sitagliptin Phosphate | 40 | $12K |
| Insulin Aspart | 36 | $11K |
| Umeclidinium Brm/Vilanterol Tr | 23 | $11K |
| Linaclotide | 15 | $10K |
| Mirabegron | 45 | $9,891 |
| Dextromethorphan Hbr/Quinidine | 11 | $8,271 |
| Duloxetine Hcl | 98 | $7,603 |
| Naloxegol Oxalate | 38 | $7,260 |
| Fentanyl | 77 | $7,081 |
Prescribing Profile
Patient Profile
75
Avg Age
58%
Female
1.77
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data